Filing Flows › Innoviva (INVA) › How it makes money
How Innoviva (INVA) makes money
Innoviva (INVA) made $106M of revenue in the third quarter 2026 (Q3 2026), -2% from a year earlier. Royalty brought in $54.7M (52%); Product brought in $49.4M (47%); License and Other Revenue brought in $2.0M (2%).
Drawing the Sankey…
Revenue by segment, Q3 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Royalty | $54.7M | 51.5% | -3% | -9% |
| Product | $49.4M | 46.6% | -4% | +5% |
| ↳ Giapreza | $23.2M | 21.9% | +4% | +26% |
| ↳ Xacduro | $22.0M | 20.7% | -2% | -8% |
| ↳ Xerava | $3.6M | 3.4% | -47% | -27% |
| ↳ ZEVTERA | $624K | 0.6% | +78% | +452% |
| License and Other Revenue | $2.0M | 1.9% | -82% | +231% |
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $106M | 100.0% |
| Operating cash flow | $41.7M | 39.3% |
| Free cash flow | $41.7M | 39.3% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $106M | -2% |
| Q2 2026 | $120M | +19% |
| Q1 2026 | $98.0M | +11% |
| Q4 2025 | $115M | +25% |
| Q3 2025 | $108M | +20% |
| Q2 2025 | $100M | +0.4% |
| Q1 2025 | $88.6M | +14% |
From Innoviva's 10-Q filed Nov 4, 2026 (on EDGAR).
Questions
How does Innoviva make money?
Innoviva (INVA) made $106M of revenue in the third quarter 2026 (Q3 2026), -2% from a year earlier. Royalty brought in $54.7M (52%); Product brought in $49.4M (47%); License and Other Revenue brought in $2.0M (2%).
What is Innoviva's biggest business?
Royalty: $54.7M in the third quarter 2026, 52% of revenue, -9% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.